Increasingly, e-clinical applications are leaving proprietary coding behind them in favor of more openly available code. One advocate of the open approach is the National Cancer Institute. Its cancer Biomedical Informatics Grid, which links researchers, physicians, and patients, is built on open-source principles.
Bio IT World reports that caBIG, in developing its platform, has consumed more than $200 million over six years. Yet only a handful of sites are operational, according to the article.
Much of the functionality that caBIG seeks, however, is available in a clinical research platform from Velos eResearch. Over the same six-year period and for "far less money," the Velos platform has been adopted by about 35 percent of the nation's NCI-designated cancer centers, says Velos CEO John McIlwain, in the article.
The caBIG open-source Clinical Trials Suite version 2.0 debuted recently. It bundles patient, adverse-event, and lab data, as well as clinical functionality.
- see the story